Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension

Published:2016-06 Issue:6 Volume:149 Page:1482-1493
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Huertas Alice,Phan Carole,Bordenave Jennifer,Tu Ly,Thuillet Raphaël,Le Hiress Morane,Avouac Jérôme,Tamura Yuichi,Allanore Yannick,Jovan Roland,Sitbon Olivier,Guignabert Christophe,Humbert Marc

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference52 articles.

1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2. Updated clinical classification of pulmonary hypertension;Simonneau;J Am Coll Cardiol,2013

3. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era;Humbert;Circulation,2010

4. Validation of two predictive models for survival in pulmonary arterial hypertension;Sitbon;Eur Respir J,2015

5. Genetics and genomics of pulmonary arterial hypertension;Soubrier;J Am Coll Cardiol,2013

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management;International Journal of Molecular Sciences;2024-08-01

2. Bibliometric analysis of T‐cells immunity in pulmonary hypertension from 1992 to 2022;Immunity, Inflammation and Disease;2024-07

3. Fibroblasts in Pulmonary Hypertension: Roles and Molecular Mechanisms;Cells;2024-05-25

4. Rare immune-related adverse effect of pembrolizumab: pulmonary hypertension;Journal of Chemotherapy;2024-05-08

5. Dysfunctional regulatory T cell: May be an obstacle to immunotherapy in cardiovascular diseases;Biomedicine & Pharmacotherapy;2024-04